ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.906,55
-0,32%
S&P 500
5.460,48
-0,41%
US Dollar vs BRL
5,59338
0,00%
Bitcoin
61.425,46
0,88%
Brent Oil
84,85
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Yumanity Therapeutics Inc (YMTX)

  7. Yumanity Therapeutics Inc (YMTX) Notícias

YMTX

Yumanity Therapeutics (YMTX)

Yumanity Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:YMTX
DataHoraFonteTítuloCódigoCompanhia
16/12/202216:58Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:YMTXYumanity Therapeutics Inc
16/12/202212:38Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:YMTXYumanity Therapeutics Inc
15/12/202208:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202218:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202218:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
05/12/202209:30GlobeNewswire Inc.Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with KinetaNASDAQ:YMTXYumanity Therapeutics Inc
14/11/202210:45Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:YMTXYumanity Therapeutics Inc
14/11/202210:16GlobeNewswire Inc.Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
14/11/202208:09Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202218:27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202218:15GlobeNewswire Inc.Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.NASDAQ:YMTXYumanity Therapeutics Inc
04/11/202217:53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:YMTXYumanity Therapeutics Inc
29/08/202207:30GlobeNewswire Inc.Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with KinetaNASDAQ:YMTXYumanity Therapeutics Inc
04/08/202217:15GlobeNewswire Inc.Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
06/06/202207:30GlobeNewswire Inc.Yumanity Therapeutics Announces Definitive Agreements for Two Strategic TransactionsNASDAQ:YMTXYumanity Therapeutics Inc
12/05/202217:45GlobeNewswire Inc.Yumanity Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
25/04/202217:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:YMTXYumanity Therapeutics Inc
25/04/202217:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:YMTXYumanity Therapeutics Inc
24/03/202217:36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:YMTXYumanity Therapeutics Inc
24/03/202217:15GlobeNewswire Inc.Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
17/02/202210:30GlobeNewswire Inc.Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces RestructuringNASDAQ:YMTXYumanity Therapeutics Inc
14/02/202219:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:YMTXYumanity Therapeutics Inc
04/02/202220:48GlobeNewswire Inc.Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:YMTXYumanity Therapeutics Inc
19/01/202209:30GlobeNewswire Inc.Yumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739  NASDAQ:YMTXYumanity Therapeutics Inc
11/01/202210:00GlobeNewswire Inc.Yumanity’s Approach to Neurodegenerative Diseases Validated by Two External CollaborationsNASDAQ:YMTXYumanity Therapeutics Inc
04/01/202210:00GlobeNewswire Inc.Yumanity Therapeutics to Present at the H.C. Wainwright BioConnect ConferenceNASDAQ:YMTXYumanity Therapeutics Inc
20/12/202118:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:YMTXYumanity Therapeutics Inc
03/12/202118:17Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:YMTXYumanity Therapeutics Inc
19/11/202118:56Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:YMTXYumanity Therapeutics Inc
16/11/202118:30GlobeNewswire Inc.Yumanity Therapeutics to Present at Multiple Upcoming November Investor ConferencesNASDAQ:YMTXYumanity Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:YMTX

Seu Histórico Recente

BTRX
EPTTUSDT
Evident Proof Transaction Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados